ASCO 2025

With experience supporting over 840 oncology and haematologic malignancy phase 1-4 studies in the past five years, ICON offers the most comprehensive span of clinical development services to plan and deliver oncology clinical trials, including small molecules, biologics, combination products, and companion diagnostics. Our flexible and fully customisable solutions support all elements of drug development from candidate selection through to market authorisation and patient access. 

Meet our experts at ASCO, Booth #30131 to learn about ICON’s full suite of services to support your Oncology clinical development programme.

• Oncology Drug Development Consultancy Services
• Early Phase Oncology
• Feasibility, Site & Patient Recruitment, Site Networks
• Centre for Cell & Gene Therapy
• Centre for Pediatric Clinical Development
• Decentralised Clinical Trials, including In-Home Services
• Central, Bioanalytical and Specialty Laboratories
• Cardiac Safety Solutions
• Medical Imaging
• Global Regulatory Consulting
• Real World Data Intelligence and Commercialisation & Outcomes